Status | Study |
Recruiting |
Study Name: A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens Condition: Carcinoma, Non-Small-Cell Lung Carcinoma, Small Cell Date: 2017-03-23 Interventions: Diagnostic Test: PD-L1 Immunocytochemistry (ICC) |
Recruiting |
Study Name: Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma Condition: Small Cell Carcinoma Date: 2016-08-23 Interventions: Drug: Nortriptyline Hydrochloride |
Recruiting |
Study Name: HS-WBRT for Prophylactic Cranial Irradiation in Limited Stage Small Cell Lung Cancer Condition: Carcinoma, Small Cell Lung Date: 2016-03-25 Interventions: Radiation: HS-WBRT PCI LD-SCLC |
Not yet recruiting |
Study Name: Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer Condition: Carcinoma, Small Cell Lung Neoplasms Date: 2016-02-03 Interventions: Radiation: high-dose TRT every |
Not yet recruiting |
Study Name: Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC Condition: Carcinoma, Small Cell Lung Neoplasms Date: 2015-11-20 Interventions: Radiation: hypofractionated concurrent chemoradiotherapy |
Recruiting |
Study Name: TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES) Condition: Carcinoma, Small Cell Date: 2015-11-10 Interventions: Drug: ARQ197 Other Name: Tivantinib |
Recruiting |
Study Name: Neurocognitive Function After Prophylactic Cranial Irradiation & Hippocampal Sparing in LD SCLC Patients - a Pilot Study Condition: Carcinoma, Small Cell Date: 2015-01-29 Interventions: Radiation: Whole brain radiotherapy with reduced dose to the hippocampi VMAT plan to treat the whole bra |
Active, not recruiting |
Study Name: Temozolomide as Maintenance Therapy in Small Cell Lung Cancer Condition: Carcinoma, Small Cell Date: 2013-07-11 Interventions: Drug: Temozolomide |
Completed |
Study Name: Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer Condition: Small Cell Carcinoma of Lung Date: 2012-06-27 Interventions: Drug: Irinotecan irinotecan 180mg/m2 i.v. over 30 min d1,q2w |
Active, not recruiting |
Study Name: Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient Condition: Carcinoma, Small Cell Date: 2009-01-21 Interventions: Drug: Belotecan/Cisplatin Belo |